Clinical Trial to Evaluate Immunotherapy Drug
June 30, 2026
June 30, 2026
NORMAN, Oklahoma, June 30 -- The University of Oklahoma issued the following news:
* * *
Clinical Trial to Evaluate Immunotherapy Drug
*
OKLAHOMA CITY - Muhammad Furqan, M.D., professor of hematology-oncology at the University of Oklahoma College of Medicine and Associate Director of Clinical Research at OU Health Stephenson Cancer Center, is leading a national clinical trial evaluating whether immunotherapy can improve outcomes for patients wi . . .
* * *
Clinical Trial to Evaluate Immunotherapy Drug
*
OKLAHOMA CITY - Muhammad Furqan, M.D., professor of hematology-oncology at the University of Oklahoma College of Medicine and Associate Director of Clinical Research at OU Health Stephenson Cancer Center, is leading a national clinical trial evaluating whether immunotherapy can improve outcomes for patients wi . . .